MBRX

Moleculin Biotech (MBRX)

About Moleculin Biotech (MBRX)

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.

Details

Daily high

$2.50

Daily low

$2.35

Price at open

$2.41

52 Week High

$28.61

52 Week Low

$1.79

Market cap

12.9M

Dividend yield

0.00%

Volume

55,754

Avg. volume

97,801

P/E ratio

-.06

Moleculin Biotech News